ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

CVAT Cavitation Technologies Inc (QB)

0.01189
0.00064 (5.69%)
24 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Cavitation Technologies Inc (QB) USOTC:CVAT OTCMarkets Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00064 5.69% 0.01189 0.0118 0.0128 0.0119 0.01 0.0101 137,394 20:29:14

Notification That Quarterly Report Will Be Submitted Late (nt 10-q)

14/05/2020 7:10pm

Edgar (US Regulatory)


 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON D.C. 20549

 

FORM 12b-25

NOTIFICATION OF LATE FILING

 

OMB Number

3235-0058

SEC File Number

000-54761

CUSIP Number

65511R204

 

(Check One) ☐ Form 10-K   ☐ Form 20-F   ☐Form 11-K    Form 10-Q    ☐ Form N-CEN

 

For Period Ended:     March 31, 2020    

☐ Transition Report on Form 10-K

☐ Transition Report on Form 20-F

☐ Transition Report on Form 11-K

☐ Transition Report on Form 10-Q

For the Transition Period Ended: ________________________

 

Read Instruction (on back page) Before Preparing Form. Please Print or Type.

Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

 

 

PART I - REGISTRANT INFORMATION

 

Cavitation Technologies, Inc.

 

Full Name of Registrant:

 

 

 

Former Name if applicable

 

10019 Canoga Avenue

 

Address of Principal Executive Office (Street and Number)

 

Chattsworth, California 91311

 

City, State, Zip Code

 

PART II. RULES 12B-25 (B) AND (C)

 

If the subject report could not be filed without unreasonable effort or expense and the Company seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check appropriate box.)

 

    (a) The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
    (b) The subject annual report, semi-annual report, transition report on Form 10-K, 20-F, 11-K, Form N-CEN, or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q, or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
    (c) The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

  1  

 

 

PART III. NARRATIVE

 

State below in reasonable detail the reasons why Form 10-K, 11-K, 20-F, 10-Q, 10-D, NCEN, N-CSR, or the transition report portion thereof could not be filed within the prescribed time period.

 

The Company is unable to file its Quarterly Report on Form 10-Q for its quarterly period ended March 31, 2020 by the prescribed date without unreasonable effort or expense because the Company was unable to compile certain information required in order to permit the Company to file a timely and accurate report on the Company’s financial condition. The Company believes that the Quarterly Report will be completed within the five day extension period provided under Rule 12b-25 of the Securities Exchange Act of 1934.

 

PART IV. OTHER INFORMATION

 

(1)           Name and telephone number of person to contact in regard to this notification:

 

Igor Gorodnitsky (818) 718-0905

 

(2)           Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the Company was required to file such report(s) been filed? If the answer is no, identify report(s).

 

x    Yes ¨   No

  

(3)           Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings to be included in the subject report or portion thereof?

 

¨    Yes x   No

   

 

Cavitation Technologies, Inc. has caused this notification to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

  CAVITATION TECHNOLOGIES, INC.
     
Dated:  May 14, 2020 By:     /s/ Igor Gorodnitsky
    Igor Gorodnitsky
    Chairman and President

 

 

 

 

 

 

 

 

 

 

 

  2  

 

 

1 Year Cavitation Technologies (QB) Chart

1 Year Cavitation Technologies (QB) Chart

1 Month Cavitation Technologies (QB) Chart

1 Month Cavitation Technologies (QB) Chart

Your Recent History

Delayed Upgrade Clock